Insider Shareholders with Direct Ownership of Acelrx Pharmaceuticals Inc (ACRX)
This section provides a comprehensive overview of the insiders with direct ownership of Acelrx Pharmaceuticals Inc (ACRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
ACELRX PHARMACEUTICALS INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Mark G Edwards
Director |
10,000 | 0 | 261,250 $295,212 | 1 |
Jun 17, 2021
Added 3.69%
|
|
Vincent J. Angotti
CHIEF EXECUTIVE OFFICER |
770,827 | 154,817 | 190,459 $215,218 | 29 |
Feb 14, 2025
Reduced 5.26%
|
|
Pamela P Palmer
Chief Medical Officer |
215,375 | 64,846 | 59,149 $66,838 | 17 |
Mar 03, 2024
Reduced 0.76%
|
|
Shakil Aslam
Chief Medical Officer |
5,695 | 0 | 37,695 $42,595 | 2 |
Jun 14, 2024
Added 11.71%
|
|
Raffi Asadorian
Chief Financial Officer |
210,125 | 53,546 | 32,214 $36,401 | 19 |
Feb 14, 2025
Reduced 9.15%
|
|
Badri N Dasu
Chief Engineering Officer |
167,042 | 39,737 | 27,011 $30,522 | 18 |
Feb 14, 2025
Reduced 8.92%
|
| 28,255 | 0 | 13,342 $15,076 | 4 |
Jun 24, 2024
Added 14.01%
|
|
|
Howard B Rosen
Director |
26,081 | 0 | 5,293 $5,981 | 3 |
Oct 10, 2023
Added 9.89%
|
| 43,255 | 0 | 4,780 $5,401 | 5 |
Jun 24, 2024
Added 31.26%
|
|
| 28,255 | 0 | 4,592 $5,188 | 4 |
Jun 24, 2024
Added 32.13%
|
|
| 28,255 | 0 | 4,592 $5,188 | 4 |
Jun 24, 2024
Added 32.13%
|
|
| 33,255 | 0 | 4,280 $4,836 | 4 |
Jun 24, 2024
Added 33.68%
|
|
| 3,045 | 0 | 3,045 $3,440 | 2 |
Jun 24, 2024
Added 41.66%
|
|
|
Richard Afable
Director |
26,081 | 0 | 2,468 $2,788 | 3 |
Oct 10, 2023
Added 19.06%
|